In addition to fibrosis, numerous studies have documented that an overactive endocannabinoid/CB1R system contributes to visceral obesity and its complications (37), including type-2 diabetes (21), and also play a role in the pathology of alcoholic liver disease (38) and viral hepatitis (39). Here, CNR1 is linked to type 2 diabetes mellitus.